- Extensive professional review. All clinical research at URMC is reviewed by panels of doctors, researchers, and community members to help protect the health and safety of participants. If, for any reason at any time, the doctor or researcher feels a study is not in a participant's best interest they will withdraw that person from the study. Remember, in the four phases of a clinical trial, the first phase is dedicated entirely to evaluating safety-related concerns for a new study.
- Widespread community considerations. We also work with Community Advisory Boards to help us understand priorities regarding research and how it impacts the community.
- Strict federal regulations. In addition to the above listed safeguards, most clinical research is federally regulated. Numerous laws and guidelines help protect the safety and privacy of participants in clinical research. For example, the Institutional Review Board (IRB), made up of an independent committee, must approve and monitor every clinical trial in the U.S. The IRB is highly concerned with protecting the rights of study participants and ethics. Researchers have to do a lot of reporting so their findings can be monitored but volunteer names are not mentioned in these reports; your identity remains secret and protected.
Reporting Safety Concerns
If you need to report a current safety concern, please contact the Research Subject Review Board.